KD
KKR's Dawn Biopharma
Venture Capital
Part of KKR
Dawn Biopharma is an investment platform controlled by KKR Healthcare Strategic Growth Fund II, focused on building a diverse portfolio of biopharma companies. Founded in 2022.
Growth
Biotech
Healthcare
- Headquarters
- United States
- Founded
- 2022